Daito Chemix announced its six-month results for the fiscal year ending March 2027, reporting ordinary profit of ¥727 million, above the preliminary forecast of ¥600 million. It also revised its full-year ordinary profit outlook upward to ¥1,400 million.
On 29 October, Daito Chemix announced ordinary profit of ¥727 million for its six-month results for the fiscal year ending March 2027. This exceeded the company's preliminary forecast of ¥600 million by 21.2%.
In its full-year earnings forecast announced the same day, ordinary profit was revised upward to ¥1,400 million. This was an increase from the previous forecast of ¥1,150 million, representing a high-level outlook for 56.6% growth.
The announcement was also listed in IFIS Japan's information section, potentially increasing market attention to Daito Chemix shares.